{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:41:54Z","timestamp":1776692514241,"version":"3.51.2"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024QD081"],"award-info":[{"award-number":["ZR2024QD081"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M741505"],"award-info":[{"award-number":["2023M741505"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["42406090"],"award-info":[{"award-number":["42406090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biopha.2026.119005","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:30:39Z","timestamp":1768962639000},"page":"119005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Saccharina japonica derived fucoidan potentiates immune checkpoint blockade therapy by modulating the survival and differentiation fate of myeloid-derived suppressor cells"],"prefix":"10.1016","volume":"195","author":[{"given":"Zhenzhen","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2026.119005_bib1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.trecan.2018.04.001","article-title":"Immunotherapy and prevention of pancreatic cancer","volume":"4","author":"Morrison","year":"2018","journal-title":"Trends Cancer"},{"issue":"9","key":"10.1016\/j.biopha.2026.119005_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.5732\/cjc.014.10118","article-title":"Novel anti-melanoma treatment: focus on immunotherapy","volume":"33","author":"Hao","year":"2014","journal-title":"Chin. J. Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2026.119005_bib3","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s11912-022-01339-4","article-title":"Immune checkpoint inhibitors and novel immunotherapy approaches for breast cancer","volume":"24","author":"Cejuela","year":"2022","journal-title":"Curr. Oncol. Rep."},{"issue":"6382","key":"10.1016\/j.biopha.2026.119005_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biopha.2026.119005_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/annonc\/mdy518","article-title":"Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study","volume":"30","author":"Adams","year":"2019","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119005_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202203699","article-title":"The single-cell landscape of intratumoral heterogeneity and the immunosuppressive microenvironment in liver and brain metastases of breast cancer","volume":"10","author":"Zou","year":"2023","journal-title":"Adv. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2026.119005_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-021-00799-6","article-title":"Elimination of acquired resistance to PD-1 blockade via the concurrent depletion of tumour cells and immunosuppressive cells","volume":"5","author":"Xue","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"3","key":"10.1016\/j.biopha.2026.119005_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030561","article-title":"Myeloid-derived suppressor cells as a therapeutic target for cancer","volume":"9","author":"Law","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.biopha.2026.119005_bib9","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3892\/ol.2017.6305","article-title":"Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer","volume":"14","author":"Gonda","year":"2017","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2026.119005_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119005_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01680","article-title":"The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion","volume":"11","author":"De Cicco","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119005_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121453","article-title":"Maitake ?-glucan promotes differentiation of monocytic myeloid-derived suppressor cells into M1 macrophages","volume":"317","author":"Masuda","year":"2023","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119005_bib13","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1002\/ptr.7784","article-title":"Ginger polysaccharide promotes myeloid-derived suppressor cell apoptosis by regulating lipid metabolism","volume":"37","author":"Song","year":"2023","journal-title":"Phytother. Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.119005_bib14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/ptr.7348","article-title":"Immunomodulatory effects of polysaccharides from marine algae for treating cancer, infectious disease, and inflammation","volume":"36","author":"Hwang","year":"2022","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2026.119005_bib15","article-title":"Fucoidan inhibits CCL22 production through NF-kappaB pathway in M2 macrophages: a potential therapeutic strategy for cancer","volume":"6","author":"Sun","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2026.119005_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020421","article-title":"Oligo-fucoidan prevents M2 macrophage differentiation and HCT116 tumor progression","volume":"12","author":"Chen","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.biopha.2026.119005_bib17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijbiomac.2010.05.010","article-title":"Structural studies on a novel fucogalactan sulfate extracted from the brown seaweed Laminaria japonica","volume":"47","author":"Wang","year":"2010","journal-title":"Int. J. Bio Macromol."},{"key":"10.1016\/j.biopha.2026.119005_bib18","article-title":"Targeted regulation of tumor microenvironment through the inhibition of MDSCs by curcumin loaded self-assembled nano-filaments","volume":"15","author":"Wang","year":"2022","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.biopha.2026.119005_bib19","first-page":"35","article-title":"MDSCs in cancer: conceiving new prognostic and therapeutic targets","volume":"1865","author":"De Sanctis","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.biopha.2026.119005_bib20","article-title":"Effect of anti-VEGF therapy on MDSCs' population in the peripheral blood of non-small cell lung cancer (NSCLC) patients","volume":"10","author":"Koinis","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119005_bib21","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.954829","article-title":"Myeloid derived suppressor cells-an overview of combat strategies to increase immunotherapy efficacy","volume":"4","author":"Draghiciu","year":"2015","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.biopha.2026.119005_bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/0022034510381264","article-title":"TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk","volume":"90","author":"Brown","year":"2011","journal-title":"J. Den. Res."},{"issue":"4","key":"10.1016\/j.biopha.2026.119005_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0021-2015","article-title":"Multifaceted functions of NOD-like receptor proteins in myeloid cells at the intersection of innate and adaptive immunity","volume":"4","author":"Kufer","year":"2016","journal-title":"Microbiol. Spectr."},{"issue":"9","key":"10.1016\/j.biopha.2026.119005_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2005.06.009","article-title":"TLR signalling and activation of IRFs: revisiting old friends from the NF-\u03baB pathway","volume":"26","author":"Moynagh","year":"2005","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119005_bib25","doi-asserted-by":"crossref","first-page":"E566","DOI":"10.1073\/pnas.1424927112","article-title":"Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils","volume":"112","author":"Casbon","year":"2015","journal-title":"Proc. Nat. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.biopha.2026.119005_bib26","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.4049\/jimmunol.1201449","article-title":"Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer","volume":"190","author":"Yu","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2026.119005_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00672","article-title":"Resistance mechanisms of anti-PD1\/PDL1 therapy in solid tumors","volume":"8","author":"Lei","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"issue":"13","key":"10.1016\/j.biopha.2026.119005_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133178","article-title":"Implications for immunotherapy of breast cancer by understanding the microenvironment of a solid tumor","volume":"14","author":"Franzen","year":"2022","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.biopha.2026.119005_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1494113","article-title":"Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: a meta-analysis of 40 studies","volume":"7","author":"Wang","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2026.119005_bib30","article-title":"MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119005_bib31","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7150\/ijbs.85276","article-title":"Polysaccharide isolated from Grifola frondosa eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T cells responses","volume":"20","author":"Li","year":"2024","journal-title":"Int. J. Bio Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119005_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/imm.12508","article-title":"Polysaccharide agaricus blazei murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway","volume":"146","author":"Liu","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2026.119005_bib33","article-title":"Ganoderma lucidum polysaccharide (GLP) enhances antitumor immune response by regulating differentiation and inhibition of MDSCs via a CARD9-NF-\u03baB-IDO pathway","volume":"40","author":"Wang","year":"2020","journal-title":"Biosci. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2026.119005_bib34","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/ptr.6058","article-title":"An Asparagus polysaccharide fraction inhibits MDSCs by inducing apoptosis through toll-like receptor 4","volume":"32","author":"Zhang","year":"2018","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2026.119005_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.vph.2015.02.007","article-title":"The innate immune system, toll-like receptors and dermal wound healing: a review","volume":"71","author":"Portou","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119005_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2019.10.020","article-title":"TLR 7\/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages","volume":"469","author":"Liu","year":"2020","journal-title":"Cancer Lett."},{"issue":"17","key":"10.1016\/j.biopha.2026.119005_bib37","doi-asserted-by":"crossref","first-page":"11676","DOI":"10.1074\/jbc.M112.441402","article-title":"Tumor STAT1 transcription factor activity enhances breast tumor growth and immune suppression mediated by myeloid-derived suppressor cells","volume":"288","author":"Hix","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119005_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-025-01496-6","article-title":"Targeting the poliovirus receptor to activate T cells and induce myeloid-derived suppressor cells to differentiate to pro-inflammatory macrophages via the IFN-\u03b3-p-STAT1-IRF8 axis in cancer therapy","author":"Feng","year":"2025","journal-title":"Cell. Death Differ."},{"issue":"12","key":"10.1016\/j.biopha.2026.119005_bib39","article-title":"Polysaccharide from lentinus edodes inhibits the immunosuppressive function of myeloid-derived suppressor cells","volume":"7","author":"Ho","year":"2012","journal-title":"PLOS One"},{"issue":"9","key":"10.1016\/j.biopha.2026.119005_bib40","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/aps.2017.27","article-title":"The novel \u03b1-glucan YCP improves the survival rates and symptoms in septic mice by regulating myeloid-derived suppressor cells","volume":"38","author":"Liu","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.biopha.2026.119005_bib41","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201170","article-title":"Ganoderma lucidum polysaccharide (GLP) enhances antitumor immune response by regulating differentiation and inhibition of MDSCs via a CARD9-NF-kappaB-IDO pathway","volume":"40","author":"Wang","year":"2020","journal-title":"Biosci. Rep."},{"issue":"17","key":"10.1016\/j.biopha.2026.119005_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179125","article-title":"Enhancement of immune checkpoint inhibitor-mediated anti-cancer immunity by intranasal treatment of ecklonia cava fucoidan against metastatic lung cancer","volume":"22","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119005_bib43","article-title":"Fucoidan-supplemented diet potentiates immune checkpoint blockage by enhancing antitumor immunity","volume":"9","author":"Yang","year":"2021","journal-title":"Front. Cell. Dev. Bio"},{"key":"10.1016\/j.biopha.2026.119005_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116360","article-title":"Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxaliplatin","volume":"173","author":"Deng","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.biopha.2026.119005_bib45","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1021\/acsnano.7b06734","article-title":"Fucoidan prolongs the circulation time of dextran-coated iron oxide nanoparticles","volume":"12","author":"Abdollah","year":"2018","journal-title":"ACS Nano"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:21:48Z","timestamp":1772810508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226000375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":45,"alternative-id":["S0753332226000375"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119005","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Saccharina japonica derived fucoidan potentiates immune checkpoint blockade therapy by modulating the survival and differentiation fate of myeloid-derived suppressor cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119005"}}